Gentian Diagnostics AS

GENT

Company Profile

  • Business description

    Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.

  • Contact

    Bjornasveien 5
    Moss1596
    NOR

    T: +47 99339905

    https://www.gentian.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    65

Stocks News & Analysis

stocks

Wildly overvalued ASX stock is skating on thin ice

This company dominates its industry and could be flirting with regulatory intervention.
stocks

Uber flexes its network effect and delivers strong result

Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.
stocks

Ask the analyst: Are Qantas shares a value trap?

Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,102.009.10-0.10%
CAC 407,649.9914.960.20%
DAX 4023,957.6533.290.14%
Dow JONES (US)44,193.1281.380.18%
FTSE 1009,132.6231.69-0.35%
HKSE25,058.00147.370.59%
NASDAQ21,169.42252.871.21%
Nikkei 22541,059.15264.290.65%
NZX 50 Index12,887.106.940.05%
S&P 5006,345.0645.870.73%
S&P/ASX 2008,831.4012.30-0.14%
SSE Composite Index3,639.675.670.16%

Market Movers